Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

Authors: Stuart J. Wong, Theodore Karrison, D. Neil Hayes, M.S. Kies, Kevin J. Cullen, Tawee Tanvetyanon, Athanassios Argiris, Naoko Takebe, Dean Lim, Nabil F. Saba, Francis P. Worden, Jeremy L. Gilbert, Heinz‐Josef Lenz, Albiruni Ryan Abdul Razak, John D. Roberts, Everett E. Vokes, Ezra E.W. Cohen - Annals of Oncology 2015 cited by 93